Genotype®MTBDRplus and Xpert®MTB/RIF in the diagnosis of tuberculosis and resistant tuberculosis: cost analysis in a tertiary referral hospital

Genotype®MTBDRplus and Xpert®MTB/RIF in the diagnosis of tuberculosis and resistant tuberculosis: cost analysis in a tertiary referral hospital

Abstract INTRODUCTION: The present study sought to assess the mean and activity based cost (ABC) of the laboratory diagnosis for tuberculosis through the application of conventional and molecular techniques-Xpert®MTB/RIF and Genotype®MTBDRplus-in a tertiary referral hospital in Brazil. METHODS:...

Full description

Bibliographic Details
Main Authors:	Valéria Martins Soares, Isabela Neves de Almeida, Maria Cláudia Vater, Suely Alves, Lida Jouca de Assis Figueredo, Luciene Scherer, Afrânio Lineu Kritski, Wânia da Silva Carvalho, Silvana Spindola de Miranda
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Medicina Tropical (SBMT)
Series:	Revista da Sociedade Brasileira de Medicina Tropical
Subjects:	tuberculosis mycobacteria diagnosis mean cost activity based cost
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822020000100301&lng=en&tlng=en

Similar Items

Cost-effectiveness of Xpert®MTB/RIF in the diagnosis of tuberculosis: pragmatic study
by: Suely Conceição Alves da Silva, et al.
Published: (2021-02-01)

Cost analysis of smear microscopy and the Xpert assay for tuberculosis diagnosis: average turnaround time
by: Lida Jouca de Assis Figueredo, et al.
Published: (2020-09-01)

Cost analysis of GenoType® MTBDRplus and GenoType® MTBDRsl at the State Laboratory of São Paulo, Brazil
by: Lida Jouca de Assis Figueredo, et al.
Published: (2023-07-01)

Pooling sputum testing to diagnose tuberculosis using xpert MTB/RIF and xpert ultra: a cost-effectiveness analysis
by: Vibol Iem, et al.
Published: (2023-05-01)

The use of Gene-Xpert MTB RIF in the diagnosis of extrapulmonary tuberculosis in childhood and adolescence
by: Rafaela Baroni Aurilio, et al.
Published: (2020-10-01)

Clinical impact and cost analysis of the use of either the Xpert MTB Rif test or sputum smear microscopy in the diagnosis of pulmonary tuberculosis in Rio de Janeiro, Brazil
by: Anália Zuleika de Castro, et al.

Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana
by: Chawangwa Modongo, et al.
Published: (2023-11-01)

Diagnostic Evaluation of Multiplex Real Time PCR, GeneXpert MTB/RIF Assay and Conventional Methods in Extrapulmonary Tuberculosis
by: Sanjay Singh Negi, et al.
Published: (2019-01-01)

Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia
by: Abraham Tesfaye, et al.
Published: (2017-05-01)

Comparative Performance of Line Probe Assay (Version 2) and Xpert MTB/RIF Assay for Early Diagnosis of Rifampicin-Resistant Pulmonary Tuberculosis
by: Raj Narayan Yadav, et al.
Published: (2021-07-01)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
by: Michael Kakinda, et al.
Published: (2022-01-01)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda.
by: Michael Kakinda, et al.
Published: (2022-01-01)

Comparison of xpert MTB/RIF assay, line probe assay, and culture in diagnosis of pulmonary tuberculosis on bronchoscopic specimen
by: Swapna Kanade, et al.
Published: (2023-01-01)

Cost-effectiveness of active tuberculosis case finding using sputum Xpert MTB/RIF and acid-fast bacilli tests
by: Wararat Thatayu, et al.
Published: (2021-01-01)

Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia
by: Helen R. Stagg, et al.
Published: (2016-03-01)

Contribución del uso de XPERT MTB/RIF y su costo-efectividad en el diagnóstico de tuberculosis pulmonar y la resistencia a rifampicina: una comparación con métodos diagnósticos no moleculares
by: Claudia Cadavid
Published: (2021-10-01)

Systematic Review of Pooling Sputum as an Efficient Method for Xpert MTB/RIF Tuberculosis Testing during the COVID-19 Pandemic
by: Luis E. Cuevas, et al.
Published: (2021-03-01)

Urine Xpert MTB/RIF for the diagnosis of childhood tuberculosis
by: Anna Lena Lopez, et al.
Published: (2019-02-01)

Use of XpertMTB/RIF for Mycobacterium tuberculosis identification
by: Roberto Deg'Innocenti, et al.
Published: (2014-12-01)

The activity-based cost of drug-susceptibility test of Mycobacterium tuberculosis through Kit SIRE Nitratase® Plastlabor
by: Isabela Neves de Almeida, et al.
Published: (2020-01-01)

Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis.
by: Arfatur Rahman, et al.
Published: (2016-01-01)

Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF
by: Urvashi B. Singh, et al.
Published: (2023-04-01)

Use of Xpert MTB/RIF for diagnosis of pediatric tuberculosis in Indonesia
by: Rina Triasih, et al.
Published: (2020-07-01)

Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis
by: Katherine Antel, et al.
Published: (2020-01-01)

Xpert MTB/RIF Ultra assay for the detection of Mycobacterium tuberculosis in people with negative conventional Xpert MTB/RIF but chest imaging suggestive of tuberculosis in Dhaka, Bangladesh
by: Samanta Biswas, et al.
Published: (2022-01-01)

Social determinants of health and catastrophic costs associated with the diagnosis and treatment of tuberculosis
by: Adriana da Silva Rezende Moreira, et al.
Published: (2020-11-01)

Misdiagnosis of non-tuberculous mycobacteria as tuberculous by the GeneXpert MTB/RIF Ultra: Fact or fiction?
by: Christoffel J. Opperman, et al.
Published: (2024-03-01)

Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis.
by: Nhu, N, et al.
Published: (2013)

Validation and implementation of GeneXpert MTB/RIF for diagnosis of Tuberculosis in Ecuador
by: José Marcelo Ortíz-Jimenes, et al.
Published: (2019-06-01)

DIAGNOSTIC VALUE OF GENE XPERT MTB-RIF IN TUBERCULOSIS CONTROL PRACTICE
by: Zh. A. Laushkina, et al.
Published: (2016-10-01)

Performance of GeneXpert MTB/RIF in the diagnosis of extrapulmonary tuberculosis in Morocco
by: A. Aainouss, et al.
Published: (2021-10-01)

Performance of Xpert® MTB/RIF among tuberculosis outpatients in Lilongwe, Malawi
by: Tarsizio Chikaonda, et al.
Published: (2017-03-01)

Is GeneXpert MTB/RIF assay reliable for the diagnosis of pleural tuberculosis?
by: Muhammad Mudassir Shafiq, et al.
Published: (2022-06-01)

Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis
by: Suraj Kumar, et al.
Published: (2017-04-01)

Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis
by: Nhu Nguyen Thi Quynh, et al.
Published: (2013-01-01)

Clinical and CT characteristics of Xpert MTB/RIF-negative pulmonary tuberculosis.
by: Han Na Lee, et al.
Published: (2021-01-01)

Correction to: Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis
by: Katherine Antel, et al.
Published: (2020-03-01)

Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF.
by: Giulia Lombardi, et al.
Published: (2017-01-01)

Evaluation of FluoroType MTB for direct detection of Mycobacterium tuberculosis complex and GenoType MTBDRplus for determining rifampicin and isoniazid resistance
by: Gonca Erkose Genc, et al.
Published: (2018-07-01)

Establishing the cost of Xpert MTB/RIF mobile testing in high-burden peri-mining communities in South Africa
by: Naseem Cassim, et al.
Published: (2021-11-01)